(Q34469947)

English

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

Vedrana Stojanovic-Susulic

7

object named as

Vedrana Stojanovic-Susulic

0 references

object named as

Yanan Wang

2

0 references

object named as

Hanno Pijl

11

0 references

Louis M Havekes

9

object named as

Louis M Havekes

1 reference

Europe PubMed Central

2 August 2017

author name string

Edwin T Parlevliet

1

1 reference

Europe PubMed Central

2 August 2017

Janine J Geerling

3

1 reference

Europe PubMed Central

2 August 2017

Janny P Schröder-Van der Elst

4

1 reference

Europe PubMed Central

2 August 2017

Kristen Picha

5

1 reference

Europe PubMed Central

2 August 2017

Karyn O'Neil

6

1 reference

Europe PubMed Central

2 August 2017

Vedrana Stojanovic-Susulic

7

1 reference

Europe PubMed Central

2 August 2017

Tatiana Ort

8

1 reference

Europe PubMed Central

2 August 2017

Johannes A Romijn

10

1 reference

Europe PubMed Central

2 August 2017

Patrick C N Rensen

12

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

2 November 2012

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

7

1 reference

Europe PubMed Central

2 August 2017

e49152

1 reference

Europe PubMed Central

2 August 2017

11

1 reference

Europe PubMed Central

2 August 2017

copyright license

Creative Commons Attribution 4.0 International

2 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Management of type 2 diabetes: new and future developments in treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Nonalcoholic fatty liver disease: a review and update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Biology of incretins: GLP-1 and GIP

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Type 2 diabetes: principles of pathogenesis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Sterol-regulatory-element-binding protein 1c mediates insulin action on hepatic gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Model for measuring absolute rates of hepatic de novo lipogenesis and reesterification of free fatty acids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Separation of plasma lipoproteins by density-gradient ultracentrifugation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

6 July 2018

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3487842

27 October 2018

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0049152

21 January 2018

Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/23133675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide (Byetta) for type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/23133675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic dyslipidaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23133675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23133675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23133675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0049152

1 reference

Europe PubMed Central

2 August 2017

2012PLoSO...749152P

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34469947&oldid=1866283714"